Schedule 13D ownership disclosure
TRANSLATE BIO INC
Security class unavailable · CUSIP: 89374L104
Event date: 2018-06-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,697,912
- Percent of class
- 8.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-18-000378
- Form type
- SC 13D
- Filer
- GSK plc
- CIK
- CIK 1131399
- Filed
- Jul 05, 2018
- Reporting period
- Jun 27, 2018
- Description
- Schedule 13D beneficial ownership